| Variables | Number (n) | Percent (%) |
| Antibiotic associations (n = 274) |
|
|
| Monotherapy | 68 | 24.8 |
| Dual therapy | 154 | 56.2 |
| Triple therapy | 48 | 17.5 |
| Quadruple therapy | 4 | 1.5 |
| Antibiotic groups (n = 528) |
|
|
| Betalactams | 254 | 48.1 |
| Imidazoles | 120 | 22.7 |
| Aminoglycosides | 102 | 19.3 |
| Macrolides | 25 | 4.7 |
| Quinolones | 18 | 3.4 |
| Others* | 9 | 1.7 |
| Antivirals (n = 173) |
|
|
| Antiretrovirals | 158 | 91.3 |
| Aciclovir | 15 | 8.7 |
| Antiparasitics (n = 215) |
|
|
| Trimethoprim/sulfamethoxazole | 101 | 47.0 |
| Albendazole | 47 | 21.9 |
| Artemether | 32 | 14.9 |
| Artesunate | 24 | 11.2 |
| Clindamycin | 8 | 3.7 |
| Quinine | 3 | 1.4 |
| Antifungals (n = 173) |
|
|
| Fluconazole | 145 | 83.8 |
| Miconazole | 24 | 13.9 |
| Nystatin | 4 | 2.3 |